Tuscan Holdings Corp. Files for $200M SPAC IPO
by Kristi Marvin on 2019-02-13 at 11:11pm

Another new SPAC filing!  

Wedneday evening, Tuscan Holdings Corp. (THCBU), debuted their $200 million SPAC focused on the cannabis industry and will be led by Stephen Vogel, as Chairman and CEO.  Mr. Vogel is currently the President of Twelve Seas Investment Company, a $207 million SPAC focused on the Pan-Eurasian region, and was formerly Executive Chairman of Forum Merger Corporation.

This SPAC’s terms stand out for a number of reasons. As you can see below, it’s a 100% in trust, 21 month, 1 share + 1 warrant SPAC. However, you will also notice that Tuscan added the Crescent Term, but with a threshold of $9.50.  Right now, of the five deals we have on file, all of them have included the Crescent Term and all of them, except Tuscan, have used a threshold, so far, of $9.20. Plus, EarlyBirdCapital is participating in the private placement purchase of warrants (the at-risk capital) for 100,000 units of the total 535,000 units total.  That’s a $1 million purchase.

However, what’s most interesting about Tuscan is the promote.  SPACs typically see management purchase a promote that is 20% of the total offering for a nominal fee of $25,000.  Sometimes, when underwriters participate in the at-risk private placement purchase, management will issue the underwriters some of the promote shares to compensate.  However, in Tuscan’s case, SPAC management is still receiving a 20% promote, but EarlyBird will be receiving 250,000 “Representative Shares”, that they also paid a nominal $25,000 for, instead. This is essentially a roundabout way of issuing additional promote-like shares to the underwriters.  Tuscan is not including the Representative Shares in their calculation of the 20% promote shares, but if we were to lump them in anyway for practical purposes, the Tuscan promote is really 20.8%.

Is an extra 0.8% significant? Well, not really. It’s just interesting that EarlyBird had to pay $25,000 for their representative shares and the Sponsors were not willing to give up 250,000 of their 5,000,000 promote shares (without over-allotment) to their underwriters who are willing to take on approximately 20% of the Sponsor at-risk capital.  To be clear, EarlyBird is not a sponsor of Tuscan Holdings. They are just sponsor-like without actually being a sponsor.

Regardless, we now have five SPACs on file to IPO and all should happen before the end of the quarter.  That means we are on track for (at a minimum) 11 SPACs for the first quarter. That also means, we are on track to at least come close to last year’s level of 46 SPACs.  However, in all likelihood, it’s looking like we’ll exceed that number but, it’s still early in the year.  Anything can happen.

Summary of terms below:

Tuscan Terms 2-13-19

EarlyBirdCaptial, Inc. is sole book-running manager and I-Bankers Securities, Inc. is co-manager.
Graubard Miller and Ellenoff Grossman & Schole LLP are issuer’s counsel and underwriter’s counsel, respectively.

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved